These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 35653344)
21. Comprehensive analysis of the prognosis and biological significance of ROR Zheng J; Tang H; Yang Y; Yang K Environ Toxicol; 2024 Feb; 39(2):487-508. PubMed ID: 37278231 [TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma. Hu R; Lu M; She L Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444 [TBL] [Abstract][Full Text] [Related]
23. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602 [TBL] [Abstract][Full Text] [Related]
24. The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma. He L; Ren D; Lv G; Mao B; Wu L; Liu X; Gong L; Liu P Cancer Med; 2023 Jan; 12(1):852-861. PubMed ID: 35621268 [TBL] [Abstract][Full Text] [Related]
25. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
26. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment. Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056 [TBL] [Abstract][Full Text] [Related]
27. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma. Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL Front Immunol; 2022; 13():969034. PubMed ID: 36466881 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma. Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683 [TBL] [Abstract][Full Text] [Related]
29. Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis. Huang C; Liu J Genet Res (Camb); 2022; 2022():6880760. PubMed ID: 36636556 [TBL] [Abstract][Full Text] [Related]
30. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Li Y; Liu H Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446 [TBL] [Abstract][Full Text] [Related]
31. Ge J; Jiang L; Tian Y; Zheng M; Huang M; Li J J Int Med Res; 2020 Apr; 48(4):300060520919252. PubMed ID: 32517588 [TBL] [Abstract][Full Text] [Related]
32. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma. Ma C; Li H; Li X; Lu S; He J Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126 [No Abstract] [Full Text] [Related]
33. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792 [TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
35. Non-coding RNA-mediated high expression of Chen K; Gong S; Fang X; Li Q; Ye M; Li J; Huang S; Zhao Y; Liu N; Li Y; Ma J Front Immunol; 2022; 13():920136. PubMed ID: 36159813 [TBL] [Abstract][Full Text] [Related]
36. RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells. Xiang Z; Zhou S; Liang S; Zhang G; Tan Y J Oral Pathol Med; 2020 Sep; 49(8):741-750. PubMed ID: 32306431 [TBL] [Abstract][Full Text] [Related]
37. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes. Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534 [TBL] [Abstract][Full Text] [Related]
38. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma. Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470 [TBL] [Abstract][Full Text] [Related]
40. Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Wang K; Li C; Chen H; Gu P; Lu J; Zhao H; Zhuo X J Oral Pathol Med; 2024 Oct; 53(9):584-594. PubMed ID: 39295197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]